首頁 > 市場調查報告書 > 醫療設備

生技設備

市場調查報告書

商品編碼

1871297

生物樣本庫市場機會、成長促進因素、產業趨勢分析及預測（2025-2034年）

Biobanking Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034

出版日期: 2025年10月17日 | 出版商:

Global Market Insights Inc. | 英文 146 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2024 年全球生物樣本庫市場價值為 762 億美元，預計到 2034 年將以 8.1% 的複合年成長率成長至 1,645 億美元。

個人化醫療的日益普及，以及基因組學和分子生物學研究投入的不斷成長，正強勁推動著市場擴張。生物樣本庫在生物醫學創新中發揮著至關重要的作用，它能夠系統地收集、保存和分析血液、組織和DNA等生物樣本，用於臨床和治療。越來越多的人參與國家生物樣本庫項目，公眾對基因組資料利用的認知不斷提高，這進一步鞏固了生物樣本庫在現代醫療保健領域的重要性。數位平台和數據共享技術的日益整合，也促進了研究機構、製藥公司和醫療服務提供者之間的全球合作。隨著醫療保健產業向數據驅動和精準醫療模式轉型，生物樣本庫正成為支持大規模人群研究、精準診斷和藥物研發的關鍵基礎設施。標準化生物樣本庫方案的不斷改進，以及儲存和樣本管理的自動化，持續提升營運效率，並提高了生物材料在科學和臨床應用中的可及性。

市場範圍
起始年份	2024
預測年份	2025-2034
起始值	762億美元
預測值	1645億美元
複合年成長率	8.1%

2024年，設備類市佔率達到42.5%，主要得益於先進低溫冷凍機、超低溫儲存設備和自動化處理系統的日益普及。此細分市場可進一步細分為樣品儲存、運輸、處理和分析設備。大規模基因組研究和生物製藥計畫的發展，推動了高容量、高可靠性儲存解決方案的需求成長。先進的設備有助於維持生物樣本的完整性，同時減少人工操作錯誤，確保樣本在臨床和研究環境中長期保存有效。

2024年，血液製品市佔率達到30.3%，這主要得益於血液樣本在生物標記鑑定、基因檢測和臨床診斷上的廣泛應用。血液採集和保存流程的標準化使其成為用途最廣泛的生物樣本之一，也為該領域帶來了顯著優勢。血液樣本廣泛應用於免疫學、流行病學和代謝研究等諸多領域，進一步鞏固了其在生物樣本庫中的重要地位。此外，血液樣本在疾病監測、臨床檢測和公共衛生研究中的重要角色也持續強化了該領域的領先地位。

2024年，北美生物樣本庫市佔率預計將達到45.7%，這主要得益於其完善的醫療基礎設施和先進的基因組研究計畫。美國和加拿大引領該地區的成長，這主要得益於對精準醫療、癌症研究和先進生物樣本管理實踐的日益重視。政府措施和學術合作正在推動國家生物樣本庫的擴建，從而能夠有效地收集和利用生物樣本，用於臨床和藥物研究。數位化生物樣本庫系統和自動化技術的廣泛應用進一步提升了資料的可近性和質量，加速了個人化治療的研發進程。

全球生物樣本庫市場的主要參與者包括賽默飛世爾科技（Thermo Fisher Scientific）、Avantor、貝克頓·迪金森公司（Becton, Dickinson and Company）、Azenta、Cryoport、BioIVT、默克公司（Merck & Co.）、輝瑞（Pfizer）、查爾斯河實驗室（Charles Riverigen）、Scorpcan（Scorpidgen）、Scorpion） Holdings、Eurofins Scientific、Hamilton Company、BioStorage Technologies、Brooks Life Sciences 和諾華（Novartis）。生物樣本庫市場的領導企業正採取多種策略來鞏固其市場地位和競爭優勢。許多企業正在擴展其全球生物樣本庫網路，並投資自動化技術以簡化樣本處理流程並提高可擴展性。此外，企業也積極尋求策略性併購和合作，以增強資料整合、樣本多樣性和營運效率。同時，各公司也致力於開發基於雲端的生物樣本庫管理平台和先進的低溫儲存解決方案，以確保高品質的樣本保存。

產業生態系分析
- 供應商格局
- 每個階段的價值增加
- 影響價值鏈的因素
產業影響因素
- 成長促進因素
  - 基因組學和藥物研發領域的技術進步
  - 對個人化醫療的需求日益成長
  - 增加基因組研究的投資
  - 生物資訊工具與先進資料分析技術的整合
- 產業陷阱與挑戰
  - 自動化系統成本高昂
  - 與生物樣本採集相關的問題
- 市場機遇
  - 發展去中心化和移動式生物樣本庫模型
  - 拓展至多組學和縱向健康資料整合領域
成長潛力分析
監管環境
未來市場趨勢
技術格局
- 目前技術
- 新興技術
波特的分析
PESTEL 分析

第4章：競爭格局

介紹
公司市佔率分析
- 全球的
- 北美洲
- 歐洲
公司矩陣分析
主要市場參與者的競爭分析
競爭定位矩陣
關鍵進展
- 併購
- 夥伴關係與合作
- 新產品發布
- 擴張計劃

第5章：市場估算與預測：依產品與服務分類，2021-2034年

主要趨勢
裝置
- 儲存裝置
- 樣品分析設備
- 樣品處理設備
- 樣品運送設備
消耗品
- 儲存耗材
- 分析耗材
- 加工耗材
- 收集耗材
服務
- 儲存服務
- 處理服務
- 運輸服務
- 供應服務
軟體

第6章：市場估計與預測：依樣本類型分類，2021-2034年

主要趨勢
血液製品
人體組織
細胞系
核酸
生物體液
人類排泄物
其他樣本類型

第7章：市場估計與預測：依應用領域分類，2021-2034年

主要趨勢
再生醫學
生命科學研究
臨床研究
其他應用

第8章：市場估算與預測：依儲存類型分類，2021-2034年

主要趨勢
自動化存儲
手動儲存

第9章：市場估算與預測：依最終用途分類，2021-2034年

主要趨勢
生物技術和製藥公司
合約研究組織（CRO）
學術和研究機構
醫院

第10章：市場估計與預測：依地區分類，2021-2034年

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 荷蘭
亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 韓國
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
中東和非洲
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國

第11章：公司簡介

Avantor
Azenta
Becton, Dickinson and Company
BioIVT
BioStorage Technologies
Brooks Life Sciences
Charles River Laboratories
Cryoport
Eurofins Scientific
Hamilton Company
Labcorp
Merck & Co.
Novartis
Pfizer
PHC Holdings
Qiagen
STEMCELL Technologies
Tecan Trading
Thermo Fisher Scientific

簡介目錄

Product Code: 6534

The Global Biobanking Market was valued at USD 76.2 billion in 2024 and is estimated to grow at a CAGR of 8.1% to reach USD 164.5 billion by 2034.

The growing focus on personalized medicine, together with rising investments in genomics and molecular biology research, is strongly propelling market expansion. Biobanks play an essential role in biomedical innovation, enabling the systematic collection, preservation, and analysis of biological specimens such as blood, tissues, and DNA for clinical and therapeutic purposes. Increasing participation in national biobank programs and heightened public awareness of genomic data utilization are reinforcing the industry's importance in modern healthcare. The growing integration of digital platforms and data-sharing technologies is also enhancing global collaboration among research institutes, pharmaceutical companies, and healthcare providers. As the healthcare industry shifts toward data-driven and precision-based medical approaches, biobanking is emerging as a critical infrastructure that supports large-scale population studies, precision diagnostics, and drug discovery. The ongoing development of standardized biobanking protocols, along with automation in storage and sample management, continues to strengthen operational efficiency and improve the accessibility of biological materials for scientific and clinical use.

Market Scope
Start Year	2024
Forecast Year	2025-2034
Start Value	$76.2 Billion
Forecast Value	$164.5 Billion
CAGR	8.1%

In 2024, the equipment segment held a 42.5% share, supported by the growing adoption of advanced cryogenic freezers, ultra-low temperature storage units, and automated handling systems. This segment is further divided into sample storage, transport, processing, and analytical equipment. Increasing demand for high-capacity and reliable storage solutions is driven by large-scale genomic research and biopharmaceutical initiatives. Advanced equipment helps maintain biospecimen integrity while reducing manual handling errors, ensuring that samples remain viable for long-term use in both clinical and research environments.

The blood products segment held a 30.3% share in 2024, owing to the extensive use of blood samples in biomarker identification, genetic testing, and clinical diagnostics. The segment benefits from the standardized procedures for collection and preservation that make blood one of the most versatile biospecimens available. Blood samples are widely utilized in a range of studies, including immunology, epidemiology, and metabolic research, which further strengthens their contribution to biobanking. Their importance in disease surveillance, clinical testing, and public health research continues to reinforce this segment's leading position.

North America Biobanking Market held 45.7% share in 2024, supported by a strong presence of established healthcare infrastructure and advanced genomic research initiatives. The U.S. and Canada lead the region's growth, driven by increased focus on precision medicine, cancer research, and advanced biospecimen management practices. Government initiatives and academic collaborations are promoting the expansion of national biobanks, enabling efficient collection and utilization of biological samples for clinical and pharmaceutical research. The high adoption of digital biobanking systems and automation technologies is further enhancing data accessibility and quality, promoting faster progress in personalized therapy development.

Key companies operating in the Global Biobanking Market include Thermo Fisher Scientific, Avantor, Becton, Dickinson and Company, Azenta, Cryoport, BioIVT, Merck & Co., Pfizer, Charles River Laboratories, STEMCELL Technologies, Qiagen, Labcorp, Tecan Trading, PHC Holdings, Eurofins Scientific, Hamilton Company, BioStorage Technologies, Brooks Life Sciences, and Novartis. Leading players in the biobanking market are employing multiple strategies to strengthen their market presence and competitive position. Many are expanding their global biobank networks and investing in automation to streamline sample handling and improve scalability. Strategic mergers, acquisitions, and collaborations are pursued to enhance data integration, sample diversity, and operational efficiency. Companies are also focusing on developing cloud-based biobank management platforms and advanced cryogenic storage solutions to ensure high-quality sample preservation.

Chapter 1 Methodology and Scope

1.1 Market scope and definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Data mining sources
- 1.3.1 Global
- 1.3.2 Regional/country
1.4 Base estimates and calculations
- 1.4.1 Base year calculation
- 1.4.2 Key trends for market estimation
1.5 Primary research and validation
- 1.5.1 Primary sources
1.6 Forecast model
1.7 Research assumption and limitations

Chapter 2 Executive Summary

2.1 Industry 360⁰ synopsis
2.2 Key market trends
- 2.2.1 Regional trends
- 2.2.2 Product and services trends
- 2.2.3 Sample type trends
- 2.2.4 Application trends
- 2.2.5 Storage type trends
- 2.2.6 End use trends
2.3 CXO perspectives: Strategic imperatives
- 2.3.1 Key decision points for industry executives
- 2.3.2 Critical success factors for market players
2.4 Future outlook and strategic recommendations

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
- 3.1.1 Supplier landscape
- 3.1.2 Value addition at each stage
- 3.1.3 Factor affecting the value chain
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Technological advancements in genomics and drug development
  - 3.2.1.2 Increasing demand for personalized medicine
  - 3.2.1.3 Increasing investments in genomic research
  - 3.2.1.4 Integration of bioinformatics tools and advanced data analysis techniques
- 3.2.2 Industry pitfalls and challenges
  - 3.2.2.1 High cost associated with automated systems
  - 3.2.2.2 Issues related to biospecimen sample procurement
- 3.2.3 Market opportunities
  - 3.2.3.1 Development of decentralized and mobile biobanking models
  - 3.2.3.2 Expansion into multi-omics and longitudinal health data integration
3.3 Growth potential analysis
3.4 Regulatory landscape
- 3.4.1 North America
- 3.4.2 Europe
- 3.4.3 Asia Pacific
- 3.4.4 Latin America
- 3.4.5 Middle East and Africa
3.5 Future market trends
3.6 Technological landscape
- 3.6.1 Current technologies
- 3.6.2 Emerging technologies
3.7 Porter's analysis
3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

4.1 Introduction
4.2 Company market share analysis
- 4.2.1 Global
- 4.2.2 North America
- 4.2.3 Europe
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Key developments
- 4.6.1 Merger and acquisition
- 4.6.2 Partnership and collaboration
- 4.6.3 New product launches
- 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Product and services, 2021 - 2034 ($ Mn)

5.1 Key trends
5.2 Equipment
- 5.2.1 Storage equipment
- 5.2.2 Sample analysis equipment
- 5.2.3 Sample processing equipment
- 5.2.4 Sample transport equipment
5.3 Consumable
- 5.3.1 Storage consumables
- 5.3.2 Analysis consumables
- 5.3.3 Processing consumables
- 5.3.4 Collection consumables
5.4 Service
- 5.4.1 Storage services
- 5.4.2 Processing services
- 5.4.3 Transport services
- 5.4.4 Supply services
5.5 Software

Chapter 6 Market Estimates and Forecast, By Sample Type, 2021 - 2034 ($ Mn)

6.1 Key trends
6.2 Blood products
6.3 Human tissues
6.4 Cell lines
6.5 Nucleic acids
6.6 Biological fluids
6.7 Human waste products
6.8 Other sample types

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2034 ($ Mn)

7.1 Key trends
7.2 Regenerative medicine
7.3 Life-science research
7.4 Clinical research
7.5 Other applications

Chapter 8 Market Estimates and Forecast, By Storage Type, 2021 - 2034 ($ Mn)

8.1 Key trends
8.2 Automated storage
8.3 Manual storage

Chapter 9 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

9.1 Key trends
9.2 Biotechnology & pharmaceutical companies
9.3 Contract research organizations (CROs)
9.4 Academic & research institutes
9.5 Hospitals

Chapter 10 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

10.1 Key trends
10.2 North America
- 10.2.1 U.S.
- 10.2.2 Canada
10.3 Europe
- 10.3.1 Germany
- 10.3.2 UK
- 10.3.3 France
- 10.3.4 Spain
- 10.3.5 Italy
- 10.3.6 Netherlands
10.4 Asia Pacific
- 10.4.1 China
- 10.4.2 Japan
- 10.4.3 India
- 10.4.4 Australia
- 10.4.5 South Korea
10.5 Latin America
- 10.5.1 Brazil
- 10.5.2 Mexico
- 10.5.3 Argentina
10.6 Middle East and Africa
- 10.6.1 South Africa
- 10.6.2 Saudi Arabia
- 10.6.3 UAE